Arvinas Inc (ARVN)
$7.86 -0.51% Close Oct 30, 2026 Live
Arvinas stock today
Arvinas closed at $7.86 on October 30, 2026, down 0.51% on the day. Over the past year it returned -20.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $507 million.
$7.50$10.00$12.50
NovJan 2026MarMayJulSep
| Period | ARVN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.6% | -0.9% |
| 3 months | -5.3% | +2.1% |
| Year to date | -33.7% | +11.7% |
| 1 year | -20.8% | +12.4% |
| 3 years | -47.9% | +88.5% |
| 5 years | -90.9% | +76.0% |
Key statistics
- Market value
- $507M
- P/E (trailing)
- 32.8
- Price / sales
- 1.6
- 52-week range
- $6.82 to $13.83
- Next report
- Nov 3, 2026
About Arvinas
Develops protein degradation-based therapeutics for cancer and other diseases.
Sector: Health Care
More on Arvinas
- Financials: revenue, earnings and segmentsRevenue -0% in the year to Dec 2025
- Valuation: P/E history and peersP/E 32.8
- Returns: what $1,000 became$1,000 five years ago is $90.78 today
No forecast, no recommendation. This page describes Arvinas Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.